Sean Kinsella

Title: Innovations by Sean Kinsella in Electroporation Technology

Introduction

Sean Kinsella is an innovative inventor based in Oranmore, Ireland. He has made significant contributions to the field of electroporation technology, holding 2 patents that enhance the efficacy of medical treatments. His work focuses on improving the delivery of therapeutic agents to cells, which can lead to better patient outcomes.

Latest Patents

One of Sean Kinsella's latest patents is an electroporation apparatus and method. This apparatus features electroporation probe terminals that link with electrodes. A unique aspect of this invention is the injection of foam at the treatment site, which displaces blood rather than mixing with it. This method increases the contact time of a higher concentration of active agent with the tissue, resulting in greater efficacy. By utilizing foam solutions, a lower concentration of the agent can achieve the same therapeutic effect as its liquid counterpart. This innovation reduces the prevalence of side effects associated with higher concentrations. Furthermore, the foam solution enables more efficient cell electroporation, particularly when bipolar pulses are employed. This efficiency mitigates the increase in tissue conductivity typically observed with liquid solutions. As a result, a more effective cell permeabilization occurs, leading to improved outcomes when electroporation is used alone or as a tool to facilitate the uptake of molecules into the cell.

Career Highlights

Sean Kinsella is associated with Mirai Medical Limited, where he continues to develop and refine his innovative technologies. His work has positioned him as a notable figure in the medical technology sector, particularly in the area of electroporation.

Collaborations

Sean collaborates with talented individuals such as Declan Soden and Colin Forde, who contribute to the advancement of their shared goals in medical innovation.

Conclusion

Sean Kinsella's contributions to electroporation technology demonstrate his commitment to improving medical treatments through innovation. His patents reflect a deep understanding of the complexities involved in delivering therapeutic agents effectively.